查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493185

全球 HbA1c 測試設備市場：市場規模、佔有率、趨勢分析 - 按設備類型、技術、最終用途、地區、細分市場預測，2024-2030 年

HbA1c Testing Devices Market Size, Share & Trends Analysis Report By Type of Device (Point-of-care (POC) Testing Devices, Laboratory-based Testing Devices), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

預計2030年全球HbA1c檢測設備市場規模將達31.5億美元，2024年至2030年複合年成長率為6.48%。

在糖尿病盛行率不斷上升以及對準確、高效監測解決方案的需求的推動下，全球 HbA1c 檢測設備市場正在經歷顯著成長。根據 CDC 的數據，到 2021 年，將有 3,840 萬美國（佔總人口的 11.6%）患有糖尿病。其中包括 200 萬第 1 型糖尿病患者，其中約 304,000 人是兒童和青少年。該報告還強調，每年有 120 萬美國人被診斷出患有糖尿病，凸顯了對糖尿病護理和管理的持續需求。 HbA1c 測試在糖尿病管理中發揮著重要作用，它為長期血糖控制提供了寶貴的見解，並幫助醫療保健提供者最佳化患者的治療計劃。

由於對準確監測工具的需求不斷增加，血糖控制和 HbA1c 測試設備的重要性正在推動市場成長，推動技術創新和市場擴張，特別是在低收入和中等收入國家。控制不足可能會導致併發症並影響患者的生活品質和醫療費用。根據一項研究，DCCT（糖尿病控制和併發症試驗）表明，嚴格的血糖控制可以減少長期併發症，凸顯了加護治療的成本效益。在低收入和中等收入國家 (LMIC)，由於診斷延遲，血糖控制和病患教育非常重要。因此，與住院治療和併發症治療相比，越來越需要早期診斷、系統性的併發症篩檢和及時強化治療，以降低成本。

市場正在見證向即時護理 (POC) 測試設備的顯著轉變，這些設備可提供快速結果並實現及時干預和個性化治療計劃。 POC 測試設備廣泛普及居家醫療環境中，使患者能夠輕鬆有效地監測其 HbA1c 水平。這一趨勢反映出醫療保健領域越來越重視以患者為中心的護理以及遠端監控解決方案的採用。

ARKRAY, Inc.、Abbott Laboratories、Chek、Siemens Healthineers、Danaher Corporation、Bio-Rad Laboratories, Inc.、Trivitron Healthcare、EKF Diagnostics 和 Tosoh Corporation 等主要市場參與者處於 HbA1c 檢測設備創新的前沿。這些公司不斷致力於開發先進技術，提高 HbA1c 檢測設備的準確性、速度和易用性，以滿足醫療保健專業人員和患者不斷變化的需求。例如，2022 年 8 月，DxGen Corp. 和 Precision Diabetes, Inc. 合作推出了 Epithod AutoDx，這是一種用於糖尿病檢測（包括 HbA1c）的自動化照護現場分析儀。 Epithod AutoDx 的使用者友善設計可在醫生辦公室和診所等環境中快速獲得結果，滿足因疫情而增加的現場檢測需求。

HbA1c 檢測設備市場報告亮點

  • 照護現場(POC) 檢測設備在 HbA1c 檢測設備領域佔據主導佔有率，由於其在糖尿病管理中知情決策的重要應用，在預測期內以最快的複合年成長率成長。
  • 免疫測量在技術領域佔據主導地位，因為它們提供快速、簡單的測量結果。
  • 由於醫院和診所擁有先進的技術和基礎設施來有效處理這些設備，醫院和診所的最終用途細分市場將在 2023 年佔據市場主導地位。
  • 北美在 HbA1c 檢測設備產業的主導地位得益於先進的醫療基礎設施、目標疾病盛行率上升以及有利的法規環境等因素。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 HbA1c 測試設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • HbA1c 檢測設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析
    • 體積分析（實驗室測試設備）

第4章 HbA1c 檢測設備市場：設備類型估算及趨勢分析

  • 細分儀表板
  • 全球HbA1c檢測設備市場波動分析
  • 全球 HbA1c 檢測設備市場：按設備類型分類的前景
  • 實驗室測試設備
  • 照護現場(POC) 測試設備

第5章 HbA1c 檢測設備市場：技術評估與趨勢分析

  • 細分儀表板
  • 全球HbA1c檢測設備市場波動分析
  • 全球 HbA1c 檢測設備市場：技術展望
  • 免疫學測試
  • 層析法
  • 酵素測定
  • 硼酸親和層析法
  • 高效液相層析
  • 其他

第6章 HbA1c 檢測設備市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球HbA1c檢測設備市場波動分析
  • 全球 HbA1c 檢測設備市場：按最終用途分類的前景
  • 醫院/診所
  • 診斷實驗室
  • 家庭護理設置

第 7 章 HbA1c 測試設備市場：區域估計與趨勢分析 - 按設備類型、技術和最終用途

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商/通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • HUMAN
    • Trinity Biotech
    • Menarini Diagnostics srl
    • SAKAE CO. LTD.
    • Ceragem Medisys Inc
    • SEKISUI MEDICAL CO., LTD.
Product Code: GVR-4-68040-251-6

HbA1c Testing Devices Market Growth & Trends:

The global HbA1c testing devices market size is anticipated to reach USD 3.15 billion by 2030, growing at a CAGR of 6.48% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for HbA1c testing devices is witnessing significant growth, driven by the rising prevalence of diabetes and the demand for accurate and efficient monitoring solutions. According to the CDC, in 2021, 38.4 million Americans, or 11.6% of the population, had diabetes. This includes 2 million Americans with type 1 diabetes, approximately 304,000 of whom are children and adolescents. The report also highlights that 1.2 million Americans are diagnosed with diabetes annually, underscoring the persistent need for diabetes care and management. HbA1c testing plays a crucial role in diabetes management by providing valuable insights into long-term blood sugar control and assisting healthcare providers in optimizing patient treatment plans.

The importance of glycemic control and HbA1c testing devices drive market growth by increasing demand for accurate monitoring tools, fostering innovation, and expanding market reach, particularly in low- and middle-income countries. Inadequate control leads to complications, impacting patients' quality of life and healthcare costs. According to a study, the Diabetes Control and Complications Trial (DCCT) shows that strict glucose control reduces long-term complications, highlighting the cost-effectiveness of intensive treatment. In low- and middle-income countries (LMICs), owing to late diagnosis, glycemic control and patient education become crucial. This, in turn, propels the need for early diagnosis, systematic complication screening, and timely treatment intensification to lower costs compared to inpatient care and treatment of complications.

The market is witnessing a notable shift towards Point-of-care (POC) testing devices, which offer rapid results, enabling timely interventions and personalized treatment plans. POC devices are gaining extensive popularity in homecare settings, enabling patients to monitor their HbA1c levels conveniently and effectively. This trend reflects the growing emphasis on patient-centric care and adoption of remote monitoring solutions in healthcare.

Key market players such as ARKRAY, Inc., Abbott Laboratories, Chek, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Inc., Trivitron Healthcare, EKF Diagnostics, and Tosoh Corporation are at the forefront of innovation in HbA1c testing devices. These companies are constantly focusing on developing advanced technologies to enhance the accuracy, speed, and user-friendliness of HbA1c testing devices, catering to the evolving needs of healthcare professionals and patients. For instance, in August 2022 , DxGen Corp. and Precision Diabetes, Inc. partnered to launch Epithod AutoDx, an automatic point-of-care analyzer for diabetes tests, including HbA1c. With a user-friendly design, it enables rapid results in settings such as physician offices and clinics, addressing the growing demand for on-site testing amid the pandemic.

HbA1c Testing Devices Market Report Highlights:

  • Point-of-care (POC) testing devices dominated the HbA1c type of device segment and are anticipated to grow at the fastest CAGR over the forecast period owing to their vital use for informed decision-making in diabetes management.
  • Immunoassays dominated the technology segment attributed to rapid and simplified results associated with the technology.
  • The hospitals and clinics end-use segment dominated the market in 2023, which is attributed to the well-equipped advanced technology and infrastructure available in hospitals and clinics to handle these devices effectively.
  • North America dominated the HbA1c testing devices industry owing to factors such as advanced healthcare infrastructure, rising prevalence of target diseases, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type of Device
    • 1.2.2. Technology
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type of device
    • 2.2.2. Technology outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. HbA1c Testing Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of diabetes
      • 3.2.1.2. Technological advancement
      • 3.2.1.3. Development of novel testing methodologies.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices
      • 3.2.2.2. Stringent regulatory policies
  • 3.3. HbA1c Testing Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Volume Analysis (Laboratory-based Testing Devices)

Chapter 4. HbA1c Testing Devices Market: Type of Device Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global HbA1c Testing Devices Market Movement Analysis
  • 4.3. Global HbA1c Testing Devices Market by Type of Device Outlook
  • 4.4. Laboratory-based Testing Devices
    • 4.4.1. Laboratory-based Testing Devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Point-of-care (POC) Testing Devices
    • 4.5.1 Point-of-care (POC) testing devices market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. HbA1c Testing Devices Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global HbA1c Testing Devices Market Movement Analysis
  • 5.3. Global HbA1c Testing Devices Market by Technology Outlook
  • 5.4. Immunoassays
    • 5.4.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Chromatography
    • 5.5.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Enzymatic Assays
    • 5.6.1. Enzymatic Assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Boronate Affinity Chromatography
    • 5.7.1. Boronate Affinity Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. High-Performance Liquid Chromatography
    • 5.8.1. High-Performance Liquid Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. HbA1c Testing Devices Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global HbA1c Testing Devices Market Movement Analysis
  • 6.3. Global HbA1c Testing Devices Market by End-use Outlook
  • 6.4. Hospitals & Clinics
    • 6.4.1. Hospitals & Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Laboratories
    • 6.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Homecare Settings
    • 6.6.1. Homecare Settings market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. HbA1c Testing Devices Market: Regional Estimates & Trend Analysis by Type of Device, Technology, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Bio-Rad Laboratories, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. F. Hoffmann-La Roche Ltd
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Siemens Healthineers AG
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. HUMAN
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Trinity Biotech
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Menarini Diagnostics s.r.l
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. SAKAE CO. LTD.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Ceragem Medisys Inc
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. SEKISUI MEDICAL CO., LTD.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 4 North America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 7 U.S. HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 10 Canada HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 14 Europe HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 17 Germany HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 20 UK HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 23 France HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 26 Italy HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 29 Spain HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 32 Denmark HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 35 Sweden HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 38 Norway HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Aisa Pacific HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 45 China HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 48 Japan HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 51 India HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 54 South Korea HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 57 Australia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 60 Thailand HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 64 Latin America HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 67 Brazil HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 70 Mexico HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 73 Argentina HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA HbA1c testing devices market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 77 MEA HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 80 South Africa HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 86 UAE HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait HbA1c testing devices market, by type of device, 2018 - 2030 (USD Million)
  • Table 89 Kuwait HbA1c testing devices market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait HbA1c testing devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 HbA1c testing devices market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 HbA1c testing devices market driver impact
  • Fig. 17 HbA1c testing devices market restraint impact
  • Fig. 18 HbA1c testing devices market: Type of device movement analysis
  • Fig. 19 HbA1c testing devices market: Type of device outlook and key takeaways
  • Fig. 20 Laboratory-based testing devices market estimates and forecast, 2018 - 2030
  • Fig. 21 Point-of-care (POC) testing devices estimates and forecast, 2018 - 2030
  • Fig. 22 HbA1c testing devices market: Technology movement analysis
  • Fig. 23 HbA1c testing devices market: Technology outlook and key takeaways
  • Fig. 24 Immunoassays market estimates and forecast, 2018 - 2030
  • Fig. 25 Chromatography estimates and forecast, 2018 - 2030
  • Fig. 26 Enzymatic Assays market estimates and forecast, 2018 - 2030
  • Fig. 27 Boronate Affinity Chromatography market estimates and forecast, 2018 - 2030
  • Fig. 28 High-Performance Liquid Chromatography market estimates and forecast, 2018 - 2030
  • Fig. 29 Others estimates and forecast, 2018 - 2030
  • Fig. 30 HbA1c testing devices market: End-use movement analysis
  • Fig. 31 HbA1c testing devices market: End-use outlook and key takeaways
  • Fig. 32 Hospitals & clinics market estimates and forecast, 2018 - 2030
  • Fig. 33 Diagnostic laboratories estimates and forecast, 2018 - 2030
  • Fig. 34 Homecare settings market estimates and forecast, 2018 - 2030
  • Fig. 35 Global HbA1c testing devices market: Regional movement analysis
  • Fig. 36 Global HbA1c testing devices market: Regional outlook and key takeaways
  • Fig. 37 Global HbA1c testing devices market share and leading players
  • Fig. 38 North America, by country
  • Fig. 39 North America
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2018 - 2030
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 57 Denmark key country dynamics
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 59 Sweden key country dynamics
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 61 Norway key country dynamics
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 63 Asia Pacific
  • Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 65 China key country dynamics
  • Fig. 66 China market estimates and forecasts, 2018 - 2030
  • Fig. 67 Japan key country dynamics
  • Fig. 68 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2018 - 2030
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 77 Latin America
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 81 Mexico key country dynamics
  • Fig. 82 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 83 Argentina key country dynamics
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 85 Middle East and Africa
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players - HbA1c testing devices market